Auvert, B., D. Taljaard, E. Lagarde, J. Sobngwi-Tambekou, R. Sitta and A. Puren (2005). "Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial." PLoS Med 2(11): e298.



Coplan, P. M., S. B. Gupta, S. A. Dubey, P. Pitisuttithum, A. Nikas, B. Mbewe, E. Vardas, M. Schechter, E. G. Kallas, D. C. Freed, T. M. Fu, C. T. Mast, P. Puthavathana, J. Kublin, K. Brown Collins, J. Chisi, R. Pendame, S. J. Thaler, G. Gray, J. McIntyre, W. L. Straus, J. H. Condra, D. V. Mehrotra, H. A. Guess, E. A. Emini and J. W. Shiver (2005). "Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents." J Infect Dis 191(9): 1427-1434.



Estcourt, M. J., S. Letourneau, A. J. McMichael and T. Hanke (2005). "Vaccine route, dose and type of delivery vector determine patterns of primary CD8+ T cell responses." Eur J Immunol 35(9): 2532-2540.



Estcourt, M. J., A. J. McMichael and T. Hanke (2005). "Altered primary CD8+ T cell response to a modified virus Ankara(MVA)-vectored vaccine in the absence of CD4+ T cell help." Eur J Immunol 35(12): 3460-3467.



Excler, J. L. (2005). "AIDS vaccine development: perspectives, challenges & hopes." Indian J Med Res 121(4): 568-581.



Fiebig, E. W., C. M. Heldebrant, R. I. Smith, A. J. Conrad, E. L. Delwart and M. P. Busch (2005). "Intermittent low-level viremia in very early primary HIV-1 infection." J Acquir Immune Defic Syndr 39(2): 133-137.



Flynn, N. M., D. N. Forthal, C. D. Harro, F. N. Judson, K. H. Mayer, M. F. Para and H. I. V. V. S. G. rgp (2005). "Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection." J Infect Dis 191(5): 654-665.



Grundner, C., Y. Li, M. Louder, J. Mascola, X. Yang, J. Sodroski and R. Wyatt (2005). "Analysis of the neutralizing antibody response elicited in rabbits by repeated inoculation with trimeric HIV-1 envelope glycoproteins." Virology 331(1): 33-46.



Hanke, T., A. J. McMichael, M. J. Dennis, S. A. Sharpe, L. A. Powell, L. McLoughlin and S. J. Crome (2005). "Biodistribution and persistence of an MVA-vectored candidate HIV vaccine in SIV-infected rhesus macaques and SCID mice." Vaccine 23(12): 1507-1514.



Johnson, P. R., B. C. Schnepp, M. J. Connell, D. Rohne, S. Robinson, G. R. Krivulka, C. I. Lord, R. Zinn, D. C. Montefiori, N. L. Letvin and K. R. Clark (2005). "Novel adeno-associated virus vector vaccine restricts replication of simian immunodeficiency virus in macaques." J Virol 79(2): 955-965.



Larke, N., A. Murphy, C. Wirblich, D. Teoh, M. J. Estcourt, A. J. McMichael, P. Roy and T. Hanke (2005). "Induction of human immunodeficiency virus type 1-specific T cells by a bluetongue virus tubule-vectored vaccine prime-recombinant modified virus Ankara boost regimen." J Virol 79(23): 14822-14833.



Maecker, H. T., A. Rinfret, P. D'Souza, J. Darden, E. Roig, C. Landry, P. Hayes, J. Birungi, O. Anzala, M. Garcia, A. Harari, I. Frank, R. Baydo, M. Baker, J. Holbrook, J. Ottinger, L. Lamoreaux, C. L. Epling, E. Sinclair, M. A. Suni, K. Punt, S. Calarota, S. El-Bahi, G. Alter, H. Maila, E. Kuta, J. Cox, C. Gray, M. Altfeld, N. Nougarede, J. Boyer, L. Tussey, T. Tobery, B. Bredt, M. Roederer, R. Koup, V. C. Maino, K. Weinhold, G. Pantaleo, J. Gilmour, H. Horton and R. P. Sekaly (2005). "Standardization of cytokine flow cytometry assays." BMC Immunol 6(1): 13.



McDermott, A. B., D. H. O'Connor, S. Fuenger, S. Piaskowski, S. Martin, J. Loffredo, M. Reynolds, J. Reed, J. Furlott, T. Jacoby, C. Riek, E. Dodds, K. Krebs, M. E. Davies, W. A. Schleif, D. R. Casimiro, J. W. Shiver and D. I. Watkins (2005). "Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaques." J Virol 79(24): 15556-15566.



Nordstrom, E. K., M. N. Forsell, C. Barnfield, E. Bonin, T. Hanke, M. Sundstrom, G. B. Karlsson and P. Liljestrom (2005). "Enhanced immunogenicity using an alphavirus replicon DNA vaccine against human immunodeficiency virus type 1." J Gen Virol 86(Pt 2): 349-354.



Price, M. A., M. S. Cohen, I. F. Hoffman, D. Chilongozi, F. E. Martinson and T. Tembo (2005). "Collecting the essence of man: semen collection for HIV transmission studies in sub-Saharan Africa." Sex Transm Infect 81(2): 185-186.



Smit, J., K. Middelkoop, L. Myer, G. Lindegger, L. Swartz, S. Seedat, T. Tucker, R. Wood, L. G. Bekker and D. J. Stein (2005). "Socio-behaviour challenges to phase III HIV vaccine trials in Sub-Saharan Africa." Afr Health Sci 5(3): 198-206.




Suraratdecha, C., S. Saithanu and V. Tangcharoensathien (2005). "Is universal coverage a solution for disparities in health care? Findings from three low-income provinces of Thailand." Health Policy 73(3): 272-284.



Tatalick, L. M., C. J. Gerard, R. Takeya, D. N. Price, B. A. Thorne, L. M. Wyatt and P. Anklesaria (2005). "Safety characterization of HeLa-based cell substrates used in the manufacture of a recombinant adeno-associated virus-HIV vaccine." Vaccine 23(20): 2628-2638.



Thakar, M. R., L. S. Bhonge, S. K. Lakhashe, U. Shankarkumar, S. S. Sane, S. S. Kulkarni, B. A. Mahajan and R. S. Paranjape (2005). "Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef." J Infect Dis 192(5): 749-759.




Zwick, M. B., R. Jensen, S. Church, M. Wang, G. Stiegler, R. Kunert, H. Katinger and D. R. Burton (2005). "Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1." J Virol 79(2): 1252-1261.